Compile Data Set for Download or QSAR
Report error Found 677 Enz. Inhib. hit(s) with all data for entry = 592
TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280654BDBM280654(US10030020, Example 199 | US10781211, Example 199)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280655BDBM280655(US10030020, Example 200 | US10781211, Example 200)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280487BDBM280487(US10030020, Example 32 | US10781211, Example 32)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280656BDBM280656(US10030020, Example 201)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280657BDBM280657(US10030020, Example 202)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280658BDBM280658(US10030020, Example 203)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280488BDBM280488(US10030020, Example 33 | US10781211, Example 33)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280659BDBM280659(US10030020, Example 204)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280660BDBM280660(US10030020, Example 205 | US10781211, Example 205)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280661BDBM280661(US10030020, Example 206 | US10781211, Example 206)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280484BDBM280484(US10030020, Example 29 | US10781211, Example 29)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280652BDBM280652(US10030020, Example 197)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280485BDBM280485(US10030020, Example 30 | US10781211, Example 30)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280653BDBM280653(US10030020, Example 198 | US10781211, Example 198)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280654BDBM280654(US10030020, Example 199 | US10781211, Example 199)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280486BDBM280486(US10030020, Example 31 | US10781211, Example 31)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280670BDBM280670(US10030020, Example 219)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280492BDBM280492(US10030020, Example 37 | US10781211, Example 37)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280671BDBM280671(US10030020, Example 221)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280672BDBM280672(BDBM280720 | US10030020, Example 222)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280673BDBM280673(US10030020, Example 223 | US10781211, Example 223)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280493BDBM280493(US10030020, Example 38 | US10781211, Example 38)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280674BDBM280674(US10030020, Example 225 | US10781211, Example 225)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280675BDBM280675(US10030020, Example 226)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280676BDBM280676(US10030020, Example 228)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280494BDBM280494(US10030020, Example 39 | US10781211, Example 39)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280677BDBM280677(US10030020, Example 229)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280489BDBM280489(US10030020, Example 34 | US10781211, Example 34)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280662BDBM280662(US10030020, Example 209 | US10781211, Example 209)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280663BDBM280663(US10030020, Example 210 | US10781211, Example 210)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280664BDBM280664(US10030020, Example 211)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280490BDBM280490(US10030020, Example 35 | US10781211, Example 204)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280665BDBM280665(US10030020, Example 214 | US10781211, Example 214)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280574BDBM280574(BDBM280666 | US10030020, Example 119 | US10781211,...)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280667BDBM280667(US10030020, Example 216)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280491BDBM280491(US10030020, Example 36 | US10781211, Example 203)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280668BDBM280668(US10030020, Example 217 | US10781211, Example 217)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280669BDBM280669(US10030020, Example 218 | US10781211, Example 218)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280497BDBM280497(US10030020, Example 42 | US10781211, Example 42)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280498BDBM280498(US10030020, Example 43 | US10781211, Example 43)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280686BDBM280686(US10030020, Example 238)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280687BDBM280687(US10030020, Example 239)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280688BDBM280688(US10030020, Example 240 | US10781211, Example 240)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280689BDBM280689(US10030020, Example 241)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280678BDBM280678(US10030020, Example 230 | US10781211, Example 230)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280679BDBM280679(US10030020, Example 231)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Mouse)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280495BDBM280495(US10030020, Example 40 | US10781211, Example 40)
Affinity DataIC50: 100nMAssay Description:Proteomes (mouse brain membrane fraction or cell lysates) (50 μL, 1.0 mg/mL total protein concentration) were preincubated with varying concentr...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280680BDBM280680(US10030020, Example 232)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280681BDBM280681(US10030020, Example 233)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

TargetMonoglyceride lipase(Human)
Abide Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 280682BDBM280682(US10030020, Example 234)
Affinity DataIC50: 100nMT: 2°CAssay Description:Proteomes (human prefrontal cortex or cell membrane fractions) (50 μL, 1.0-2.0 mg/mL total protein concentration) were preincubated with varying...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/31/2018
Entry Details
US Patent

Displayed 1 to 50 (of 677 total ) | Next | Last >>
Jump to: